MG T4131/4151 Dissertation Proposal Example A: Draft title: Innovation in Chinese Pharmaceutical manufacturing industry: Investigation into FK Pharmaceutical Co., Ltd.1. Introduction According to the previous studies, innovation has great contribution to business success and competitiveness of organizations. Literatures indicated that more innovative firms perform better. For many companies competitive advantage is gained and maintained through innovation. However, according to some literature review, the gap between the Chinese and global pharmaceutical sectors has widened in recent years. The lag attributes to the lack of innovation in the Chinese pharmaceutical company. In this paper, the investigation into a Chinese medium pharmaceutical company—FK Pharmaceutical Co., Ltd. where I had worked for ten years will be done to explore why Chinese pharmaceutical companies lack of innovation? What are the innovation issues in a medium Chinese pharmaceutical company? How can a medium Chinese pharmaceutical company become more innovative?2. Back ground In the Chinese pharmaceutical industry, the firms whose the original value of production uses fixed asset exceed 500 million Yuan RMB and above are called large firms, otherwise are called medium or small firms. According to this criteria, FK Pharmaceutical Co., Ltd is a large company, which is one of the top 100 pharmaceutical enterprises in China in terms of total value of asset, it is located in [....], founded in [...]. In 2002 it was reformed into a corporation with a variety of shareholders. Over more than 40 years FK is steadily growing. It started from a single product to its current product ranges more than 15 products. Though FK developed a lot in the past years, the more and more competitive markets make it face many difficulties in its business. The core product faces the higher competition than ever before in the market. Improving the innovation ability, develop new products is a crucial issue for its substantial and continuous development. However, today, as most of the Chinese pharmaceutical companies, the improvement of innovation is the big challenge of FK.3. Literature review 3.1 The definition of innovation:According to West and Farr (1990), innovation refers to intentional introduction and application of ideas, processes, products and designed which can significantly contribute to the benefits of group, organisation or society.The definition of innovation described by Organization for Economic Corporation and Development (OECD) is "innovation consists of all those scientific, technical, commercial and financial steps necessary for the successful development and marketing of new or improved manufactured products, the commercial use of new or improved processes or equipment or the introduction of a new approach to a social service. R&D is only one of these steps" (OECD, 1981, pp. 15-16 cited in Simmie, J., 2007).


MG T4131/4151论文提案范例A：草案标题：中国医药制造业产业创新：调查FK药业有限公司1。介绍，根据以往的研究，创新有很大的贡献，企业的成功和竞争力的组织。文献表明，更多的创新型企业有更好的表现。对于许多公司来说，通过创新获得竞争优势并保持。然而，根据一些文献综述，中国和全球制药部门之间的差距已经扩大在最近几年。的滞后属性缺乏创新的中国制药公司。在本文中，中国中医药公司FK药业有限公司，我曾十年的调查工作将探讨为什么中国药企缺乏创新？在一个中型的中国制药公司的创新问题是什么？中国中等制药公司如何才能变得更具创新性？2。返回地面在中国医药行业中的企业，其生产用固定资产原值的超过500万元人民币及以上的称为大型企业，否则被称为中型或小型企业。根据这一标准，FK药业有限公司，是一家大公司，这是前100名制药企业在中国的总资产价值的方面之一，它坐落在[...]，[创立。 ..]。在2002年，它被改造成团与各种股东。在超过40年FK稳步增长。它开始从单一的产品，目前的产品范围超过15个产品。虽然FK开发了很多在过去几年中，越来越有竞争力的市场，其业务面临着许多困难。核心产品面临着比以往更高的竞争在市场。提高创新能力，开发新产品是其实质和持续发展的一个关键问题。然而，今天，大多数中国医药企业，改进创新是大挑战FK.3。文献回顾3.1创新的定义：据西和Farr（1990），创新是指在有意引入和应用思路，流程，产品和设计，可以显着促进组的好处，组织或社会。定义创新经济公司和发展组织（OECD）的“创新包括所有的科学，技术，商业和金融的成功开发和营销新产品或改良生产的产品，新的或改进的过程或设备的商业用途的必要步骤或引入社会服务的一种新的方法。研发这些步骤只有一个“（OECD，1981年，第15-16页中提到，2007年，J. Simmie）。